Prevalence and types of extended-spectrum β-lactamases among urinary Escherichia coli and Klebsiella spp. in New Zealand
Authors:
- Helen M. HeffernanHHHelen M. Heffernan
- Rosemary E. WoodhouseRWRosemary E. Woodhouse
- Christopher E. PopeCPChristopher E. Pope
- Timothy K. BlackmoreTBTimothy K. Blackmore
- 31 December 2009
- journal article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 34 (6) , 544-549
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Dominance of bla CTX-M within an Australian Extended-Spectrum β-Lactamase Gene PoolAntimicrobial Agents and Chemotherapy, 2008
- Community‐Onset Genitourinary Tract Infection due to CTX‐M‐15–ProducingEscherichia coliamong Travelers to the Indian Subcontinent in New ZealandClinical Infectious Diseases, 2008
- Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concernThe Lancet Infectious Diseases, 2008
- High prevalence of CTX-M-15 extended-spectrum -lactamase among contacts of patients with shigellosis due to Shigella flexneri carrying CTX-M-15Journal of Antimicrobial Chemotherapy, 2007
- Molecular Epidemiology of CTX-M-Producing Escherichia coli in the Calgary Health Region: Emergence of CTX-M-15-Producing IsolatesAntimicrobial Agents and Chemotherapy, 2007
- CTX-M β-Lactamase-Producing Escherichia coli in French Hospitals: Prevalence, Molecular Epidemiology, and Risk FactorsJournal of Clinical Microbiology, 2007
- Occurrence, prevalence and genetic environment of CTX-M -lactamases in Enterobacteriaceae from Indian hospitalsJournal of Antimicrobial Chemotherapy, 2006
- The CTX-M β-lactamase pandemicCurrent Opinion in Microbiology, 2006
- Regional variation in the prevalence of extended-spectrum β-lactamase–producing clinical isolates in the Asia-Pacific region (SENTRY 1998–2002)Diagnostic Microbiology and Infectious Disease, 2005
- Early Dissemination of CTX-M-Derived Enzymes in South AmericaAntimicrobial Agents and Chemotherapy, 2002